Yantai Dongcheng Pharmaceutical Group Co., Ltd.

Listed group with four divisions: biochemical active ingredients with vertical integration in heparin, chemical medicines, traditional Chinese medicine preparations and nuclear medicine, which it entered in 2015 through acquisitions. It presents itself as a worldwide chondroitin sulfate supplier and exports over ninety per cent of its raw materials to more than fifty countries. Founded in 1998.